ICON plc Q2 2026 Results

ICON plc reported its second quarter 2026 financial results, with revenue at $2,063.5 million, a 1.4% increase from the previous quarter. Adjusted EBITDA was $327.2 million, a 3.0% increase from Q1 2026. GAAP net income was $72.6 million, or $0.94 per diluted share, while adjusted net income was $198.4 million, or $2.56 per adjusted diluted share. The company recorded net business wins of $3,120 million, resulting in a net book-to-bill ratio of 1.51. The closing backlog stands at $23.4 billion. ICON reaffirmed its 2026 full-year financial guidance, expecting revenues between $7,850 and $8,150 million and adjusted diluted earnings per share between $10.00 and $11.00. The company highlighted disciplined cost management and strong strategic wins supporting its financial performance despite anticipated operational headwinds. Free cash flow for the quarter was $238.9 million. ICON, a clinical research organization, maintained its positive outlook based on a diversified portfolio and operational agility.